News

ITM Power Shares Climb on Increased Order Momentum
Wednesday, 01 May 2013ITM Power Plc (ITM), a U.K. energy storage and clean-fuel company, advanced the most in seven weeks after attracting sales leads at a show in Germany and winning its first contracts in Hungary and South America.
The shares rose...
[more]European Mediscience Awards 2013 - IT'S TIME TO GET VOTING!
Tuesday, 26 March 2013Nominations for the European Mediscience Awards 2013 sponsored by Nomura Code and Kempen & Co. are now open and should be completed without delay. Nominations can be made online and you may make up to three nominations for each...[more]
Placing and Subscription to raise $20.3m
Tuesday, 26 March 2013Plant Health Care plc (AIM/CISX: PHC.L), a leading provider of novel patent protected biological products to the global agriculture markets, announces that it is proposing to raise £13.4m ($20.3m) before expenses by means of a...[more]
Ablynx successfully raises €31.5 Million, in total €45 Million placed
Thursday, 28 February 2013GHENT, Belgium, 28 February 2013 - Ablynx [Euronext Brussels: ABLX], the biopharmaceutical company focused on the discovery and development of Nanobodies®, announces today that it has raised €31.5 million through a private...[more]
Nomura Code advises Glide Pharma on £14m Fundraising
Tuesday, 26 February 2013Glide Pharma Completes £14.0 Million ($21.4 Million) Fundraising For Scale Up of Drug and Device Manufacturing Processes and Product Development ...[more]
Medgenics Prices Public Offering of Common Stock and Warrants
Monday, 11 February 2013MISGAV, Israel & SAN FRANC ISC O--(BUSINESS WIRE)--Feb. 8, 2013- and AIM: MEDU, MEDG) the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has priced an...[more]

Nomura Code Securities - Reflection and Review of 2012
Monday, 21 January 2013Message from Chris Collins, CEO[more]

Biotie issues €20m of shares to institutional and strategic investors
Monday, 10 September 2012Nomura Code acted as global coordinator and joint lead manager for Biotie’s directed share issue of EUR 20 million to institutional and strategic investors sole. Biotie is a specialized drug development company focused on the...[more]